Hepatitis B and C

Joseph Carlin; Maria Cassia Mendes-Correa; Marina Núñez

doi:10.1007/978-3-319-56694-8_10

Hepatitis B and C

Joseph Carlin, Maria Cassia Mendes-Correa, Marina Núñez

Houston Methodist

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Coinfection with human immunodeficiency virus (HIV) and hepatitis C (HCV) and/or hepatitis B virus (HBV) is not uncommon as these viruses share transmission routes. With the improved survival of HIV-infected patients due to antiretroviral treatment (ART), liver disease secondary to viral hepatitis has emerged as an important cause of morbidity and mortality in this population. Therefore, screening for and monitoring these infections are an important aspect of HIV care. The interactions between HIV disease and viral hepatitis, and between the drugs required to treat these entities, pose unique challenges to the management of HBV and HCV in HIV-coinfected patients. Great progress has been made in the treatment of HBV and HCV, resulting in improved outcomes, but acute infections continue to fuel the epidemics of HIV and viral hepatitis coinfections, especially among men who have sex with men (MSM).

Original language	English (US)
Title of host publication	Sexually Transmitted Infections in HIV-Infected Adults and Special Populations
Subtitle of host publication	A Clinical Guide
Publisher	Springer International Publishing
Pages	175-189
Number of pages	15
ISBN (Electronic)	9783319566948
ISBN (Print)	9783319566924
DOIs	https://doi.org/10.1007/978-3-319-56694-8_10
State	Published - Jan 1 2017

Keywords

Anti-HCV antibody
DAA (direct-acting antivirals)
HBsAg
HBV DNA
HBV vaccine
HBV–HIV coinfection
HCV RNA
HCV–HIV coinfection
Hepatitis
Tenofovir

ASJC Scopus subject areas

General Medicine

Access to Document

10.1007/978-3-319-56694-8_10

Cite this

@inbook{e3ed309d785b42698671ef8d511e376b,

title = "Hepatitis B and C",

abstract = "Coinfection with human immunodeficiency virus (HIV) and hepatitis C (HCV) and/or hepatitis B virus (HBV) is not uncommon as these viruses share transmission routes. With the improved survival of HIV-infected patients due to antiretroviral treatment (ART), liver disease secondary to viral hepatitis has emerged as an important cause of morbidity and mortality in this population. Therefore, screening for and monitoring these infections are an important aspect of HIV care. The interactions between HIV disease and viral hepatitis, and between the drugs required to treat these entities, pose unique challenges to the management of HBV and HCV in HIV-coinfected patients. Great progress has been made in the treatment of HBV and HCV, resulting in improved outcomes, but acute infections continue to fuel the epidemics of HIV and viral hepatitis coinfections, especially among men who have sex with men (MSM).",

keywords = "Anti-HCV antibody, DAA (direct-acting antivirals), HBsAg, HBV DNA, HBV vaccine, HBV–HIV coinfection, HCV RNA, HCV–HIV coinfection, Hepatitis, Tenofovir",

author = "Joseph Carlin and Mendes-Correa, \{Maria Cassia\} and Marina N{\'u}{\~n}ez",

note = "Publisher Copyright: {\textcopyright} Springer International Publishing AG 2017.",

year = "2017",

month = jan,

day = "1",

doi = "10.1007/978-3-319-56694-8\_10",

language = "English (US)",

isbn = "9783319566924",

pages = "175--189",

booktitle = "Sexually Transmitted Infections in HIV-Infected Adults and Special Populations",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Hepatitis B and C

AU - Carlin, Joseph

AU - Mendes-Correa, Maria Cassia

AU - Núñez, Marina

N1 - Publisher Copyright: © Springer International Publishing AG 2017.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Coinfection with human immunodeficiency virus (HIV) and hepatitis C (HCV) and/or hepatitis B virus (HBV) is not uncommon as these viruses share transmission routes. With the improved survival of HIV-infected patients due to antiretroviral treatment (ART), liver disease secondary to viral hepatitis has emerged as an important cause of morbidity and mortality in this population. Therefore, screening for and monitoring these infections are an important aspect of HIV care. The interactions between HIV disease and viral hepatitis, and between the drugs required to treat these entities, pose unique challenges to the management of HBV and HCV in HIV-coinfected patients. Great progress has been made in the treatment of HBV and HCV, resulting in improved outcomes, but acute infections continue to fuel the epidemics of HIV and viral hepatitis coinfections, especially among men who have sex with men (MSM).

AB - Coinfection with human immunodeficiency virus (HIV) and hepatitis C (HCV) and/or hepatitis B virus (HBV) is not uncommon as these viruses share transmission routes. With the improved survival of HIV-infected patients due to antiretroviral treatment (ART), liver disease secondary to viral hepatitis has emerged as an important cause of morbidity and mortality in this population. Therefore, screening for and monitoring these infections are an important aspect of HIV care. The interactions between HIV disease and viral hepatitis, and between the drugs required to treat these entities, pose unique challenges to the management of HBV and HCV in HIV-coinfected patients. Great progress has been made in the treatment of HBV and HCV, resulting in improved outcomes, but acute infections continue to fuel the epidemics of HIV and viral hepatitis coinfections, especially among men who have sex with men (MSM).

KW - Anti-HCV antibody

KW - DAA (direct-acting antivirals)

KW - HBsAg

KW - HBV DNA

KW - HBV vaccine

KW - HBV–HIV coinfection

KW - HCV RNA

KW - HCV–HIV coinfection

KW - Hepatitis

KW - Tenofovir

UR - https://www.scopus.com/pages/publications/105008838085

UR - https://www.scopus.com/inward/citedby.url?scp=105008838085&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-56694-8_10

DO - 10.1007/978-3-319-56694-8_10

M3 - Chapter

AN - SCOPUS:105008838085

SN - 9783319566924

SP - 175

EP - 189

BT - Sexually Transmitted Infections in HIV-Infected Adults and Special Populations

PB - Springer International Publishing

ER -

Hepatitis B and C

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this